Literature DB >> 1316462

Mutations within the env gene of Mason-Pfizer monkey virus: effects on protein transport and SU-TM association.

B A Brody1, E Hunter.   

Abstract

By deletion mutagenesis analyses, we have examined the contribution of the immunosuppressive peptide (ISP) region within the transmembrane (TM) protein of Mason-Pfizer monkey virus to viral maturation and infectivity. Deletion of the entire region (mutant D105) results in the production of an Env precursor that is transport defective and therefore unable to be processed to mature glycoproteins. This mutation results in the release of noninfectious virions devoid of surface glycoproteins. A second deletion that removes the most highly conserved 11 amino acids of the ISP (mutant D33) does not affect the production, transport, or processing of the Env precursor yet produces virions that are noninfectious. The mutation was shown to cause the loss of interaction between the surface (SU) and TM proteins and result in the efficient shedding of gp70 into the culture medium. The released gp70 protein was biologically active and could still bind with high specificity to susceptible target cells. Since the ISP domain may represent an area of contact between SU and TM, it could provide an additional explanation for the amino acid sequence homology observed within this region of a variety of retroviruses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316462      PMCID: PMC241127     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  Retrovirus envelope glycoproteins.

Authors:  E Hunter; R Swanstrom
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Inhibition of human lymphocyte mitogen and antigen response by a 15,000-dalton protein from feline leukemia virus.

Authors:  L C Hebebrand; R G Olsen; L E Mathes; W S Nichols
Journal:  Cancer Res       Date:  1979-02       Impact factor: 12.701

3.  Cellular maturation of oncornavirus glycoproteins: topological arrangement of precursor and product forms in cellular membranes.

Authors:  O N Witte; A Tsukamoto-Adey; I L Weissman
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

4.  A rapid screening procedure for the isolation of nonconditional replication mutants of Mason-Pfizer monkey virus: identification of a mutant defective in pol.

Authors:  S Chatterjee; J Bradac; E Hunter
Journal:  Virology       Date:  1985-02       Impact factor: 3.616

5.  Effect of leukemia virus infections on antibody formation and cellular immunity.

Authors:  W S Ceglowski
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

6.  Similarity between p15E of murine and feline leukaemia viruses and p21 of HTLV.

Authors:  G J Cianciolo; R J Kipnis; R Snyderman
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

7.  Receptor interference groups of 20 retroviruses plating on human cells.

Authors:  M A Sommerfelt; R A Weiss
Journal:  Virology       Date:  1990-05       Impact factor: 3.616

8.  Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products.

Authors:  M Nelson; D S Nelson; G J Cianciolo; R Snyderman
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Preassembled capsids of type D retroviruses contain a signal sufficient for targeting specifically to the plasma membrane.

Authors:  S S Rhee; H X Hui; E Hunter
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

10.  Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.

Authors:  D T Harris; G J Cianciolo; R Snyderman; S Argov; H S Koren
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

View more
  20 in total

1.  Variable sensitivity to substitutions in the N-terminal heptad repeat of Mason-Pfizer monkey virus transmembrane protein.

Authors:  Chisu Song; Eric Hunter
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Protection of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccinia virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3).

Authors:  B A Brody; E Hunter; J D Kluge; R Lasarow; M Gardner; P A Marx
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.

Authors:  A R Rosenberg; L Delamarre; C Pique; D Pham; M C Dokhélar
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Mutational analysis of the envelope gene of Moloney murine leukemia virus.

Authors:  K D Gray; M J Roth
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41.

Authors:  S S Chen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.

Authors:  Chisu Song; Keith Micoli; Helena Bauerova; Iva Pichova; Eric Hunter
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity.

Authors:  B A Brody; S S Rhee; E Hunter
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Tumor cells expressing a retroviral envelope escape immune rejection in vivo.

Authors:  M Mangeney; T Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Delayed cytopathicity of a feline leukemia virus variant is due to four mutations in the transmembrane protein gene.

Authors:  E Thomas; J Overbaugh
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Basic residues in the Mason-Pfizer monkey virus gag matrix domain regulate intracellular trafficking and capsid-membrane interactions.

Authors:  Elizabeth Stansell; Robert Apkarian; Sarka Haubova; William E Diehl; Ewan M Tytler; Eric Hunter
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.